140 related articles for article (PubMed ID: 22397925)
1. Disruption of cyclooxygenase-2 prevents downregulation of cortical AQP2 and AQP3 in response to bilateral ureteral obstruction in the mouse.
Nilsson L; Madsen K; Topcu SO; Jensen BL; Frøkiær J; Nørregaard R
Am J Physiol Renal Physiol; 2012 Jun; 302(11):F1430-9. PubMed ID: 22397925
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase 2 inhibition exacerbates AQP2 and pAQP2 downregulation independently of V2 receptor abundance in the postobstructed kidney.
Jensen AM; Bae EH; Nørregaard R; Wang G; Nielsen S; Schweer H; Kim SW; Frøkiaer J
Am J Physiol Renal Physiol; 2010 Apr; 298(4):F941-50. PubMed ID: 20107111
[TBL] [Abstract][Full Text] [Related]
3. COX-2 inhibition prevents downregulation of key renal water and sodium transport proteins in response to bilateral ureteral obstruction.
Nørregaard R; Jensen BL; Li C; Wang W; Knepper MA; Nielsen S; Frøkiaer J
Am J Physiol Renal Physiol; 2005 Aug; 289(2):F322-33. PubMed ID: 15840770
[TBL] [Abstract][Full Text] [Related]
4. COX-2 activity transiently contributes to increased water and NaCl excretion in the polyuric phase after release of ureteral obstruction.
Nørregaard R; Jensen BL; Topcu SO; Diget M; Schweer H; Knepper MA; Nielsen S; Frøkiaer J
Am J Physiol Renal Physiol; 2007 May; 292(5):F1322-33. PubMed ID: 17229676
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II regulates V2 receptor and pAQP2 during ureteral obstruction.
Jensen AM; Bae EH; Fenton RA; Nørregaard R; Nielsen S; Kim SW; Frøkiaer J
Am J Physiol Renal Physiol; 2009 Jan; 296(1):F127-34. PubMed ID: 18971210
[TBL] [Abstract][Full Text] [Related]
6. Bilateral ureteral obstruction induces early downregulation and redistribution of AQP2 and phosphorylated AQP2.
Stødkilde L; Nørregaard R; Fenton RA; Wang G; Knepper MA; Frøkiær J
Am J Physiol Renal Physiol; 2011 Jul; 301(1):F226-35. PubMed ID: 21525134
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin prevents the downregulation of aquaporin-2 receptor after bilateral ureteral obstruction and protects renal function in a rat model.
Danilovic A; Lopes RI; Sanches TR; Shimizu MH; Oshiro FM; Andrade L; Dénes FT; Seguro AC
Urology; 2012 Aug; 80(2):485.e15-20. PubMed ID: 22503765
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of renal aquaporins in response to unilateral ureteral obstruction.
Li C; Wang W; Knepper MA; Nielsen S; Frøkiaer J
Am J Physiol Renal Physiol; 2003 May; 284(5):F1066-79. PubMed ID: 12517734
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II mediates downregulation of aquaporin water channels and key renal sodium transporters in response to urinary tract obstruction.
Jensen AM; Li C; Praetorius HA; Nørregaard R; Frische S; Knepper MA; Nielsen S; Frøkiaer J
Am J Physiol Renal Physiol; 2006 Nov; 291(5):F1021-32. PubMed ID: 16757730
[TBL] [Abstract][Full Text] [Related]
10. Urinary tract obstruction induces transient accumulation of COX-2-derived prostanoids in kidney tissue.
Nørregaard R; Jensen BL; Topcu SO; Wang G; Schweer H; Nielsen S; Frøkiaer J
Am J Physiol Regul Integr Comp Physiol; 2010 Apr; 298(4):R1017-25. PubMed ID: 20147610
[TBL] [Abstract][Full Text] [Related]
11. alpha-MSH prevents impairment in renal function and dysregulation of AQPs and Na-K-ATPase in rats with bilateral ureteral obstruction.
Li C; Shi Y; Wang W; Sardeli C; Kwon TH; Thomsen K; Jonassen T; Djurhuus JC; Knepper MA; Nielsen S; Frøkiaer J
Am J Physiol Renal Physiol; 2006 Feb; 290(2):F384-96. PubMed ID: 16189288
[TBL] [Abstract][Full Text] [Related]
12. COX-2 disruption leads to increased central vasopressin stores and impaired urine concentrating ability in mice.
Nørregaard R; Madsen K; Hansen PB; Bie P; Thavalingam S; Frøkiær J; Jensen BL
Am J Physiol Renal Physiol; 2011 Dec; 301(6):F1303-13. PubMed ID: 21880835
[TBL] [Abstract][Full Text] [Related]
13. Role of mitochondrial oxidative stress in modulating the expressions of aquaporins in obstructive kidney disease.
Liu M; Sun Y; Xu M; Yu X; Zhang Y; Huang S; Ding G; Zhang A; Jia Z
Am J Physiol Renal Physiol; 2018 Apr; 314(4):F658-F666. PubMed ID: 29357430
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 inhibitor preserves medullary aquaporin-2 expression and prevents polyuria after ureteral obstruction.
Cheng X; Zhang H; Lee HL; Park JM
J Urol; 2004 Dec; 172(6 Pt 1):2387-90. PubMed ID: 15538275
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of AQP1, -2, and -3 after ureteral obstruction is associated with a long-term urine-concentrating defect.
Li C; Wang W; Kwon TH; Isikay L; Wen JG; Marples D; Djurhuus JC; Stockwell A; Knepper MA; Nielsen S; Frøkiaer J
Am J Physiol Renal Physiol; 2001 Jul; 281(1):F163-71. PubMed ID: 11399657
[TBL] [Abstract][Full Text] [Related]
16. Regulation of aquaporins and sodium transporter proteins in the solitary kidney in response to partial ureteral obstruction in neonatal rats.
Topcu SO; Nørregaard R; Pedersen M; Wang G; Jørgensen TM; Frøkiær J
Urol Int; 2011; 87(1):94-104. PubMed ID: 21677414
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of aquaporins in the kidneys of streptozotocin-induced diabetic mice.
Leung JC; Chan LY; Tsang AW; Tang SC; Lai KN
Nephrology (Carlton); 2005 Feb; 10(1):63-72. PubMed ID: 15705184
[TBL] [Abstract][Full Text] [Related]
18. Aliskiren restores renal AQP2 expression during unilateral ureteral obstruction by inhibiting the inflammasome.
Wang W; Luo R; Lin Y; Wang F; Zheng P; Levi M; Yang T; Li C
Am J Physiol Renal Physiol; 2015 Apr; 308(8):F910-22. PubMed ID: 25694485
[TBL] [Abstract][Full Text] [Related]
19. Bilateral ureteral obstruction is rapidly accompanied by ER stress and activation of autophagic degradation of IMCD proteins, including AQP2.
Somparn P; Boonkrai C; Charngkaew K; Chomanee N; Hodge KG; Fenton RA; Pisitkun T; Khositseth S
Am J Physiol Renal Physiol; 2020 Jan; 318(1):F135-F147. PubMed ID: 31736351
[TBL] [Abstract][Full Text] [Related]
20. Increased renal adrenomedullin expression in rats with ureteral obstruction.
Nørregaard R; Bødker T; Jensen BL; Stødkilde L; Nielsen S; Frøkiaer J
Am J Physiol Regul Integr Comp Physiol; 2009 Jan; 296(1):R185-92. PubMed ID: 18945953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
